Admedus introduces heart tissue technology to India - Proactive Investors Australia

Proactive Investors Australia
Admedus introduces heart tissue technology to India
Proactive Investors Australia
Admedus Ltd (ASX:AHZ) is introducing its ADAPT® engineered tissue technology to India, a country with circa 50 million cardiac patients and 280,000 babies born annually with a Congenital Heart Defect. Physicians in India now have access to the benefits ...and more »